A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection

A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection

The effective protective HIV vaccine should elicit either protective antibodies or effective T cell response, or both. To improve the efficacy of HIV-1 vaccines, HLA polymorphism and HIV-1 diversity are 2 key factors to be considered for vaccine development. In this study, we expressed a recombinant...

Full description

Bibliographic Details
Main Authors: Yi Yang, Qing Zhu, Weilai Sun, Jingjing Guo, Xiuzhe Ning, Qiao Li, Yan Guo, Junfeng Li, Zhihua Kou, Yusen Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2017-06-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
adjuvant
aids
antibody
hiv-1
memory immune responses
multi-epitope protein
t cell responses
Online Access:http://dx.doi.org/10.1080/21645515.2017.1281488

Similar Items

Similar Items